Literature DB >> 15463872

Increased expression of Interleukin-13 but not Interleukin-4 in cystic fibrosis patients.

Hans-Peter Hauber1, Djalal Gholami, Gerhard Koppermann, Hans-Eberhard Heuer, Andreas Meyer, Almuth Pforte.   

Abstract

BACKGROUND: Many patients with cystic fibrosis (CF) suffer from allergic disease, which can complicate treatment of CF lung disease. Interleukin (IL)-4 and IL-13 have been shown to be important mediators in allergic disease.
OBJECTIVE: To investigate the role of IL-4 and IL-13 in allergic and non-allergic CF patients.
METHODS: Expression of IL-4 and IL-13 mRNA was investigated in peripheral blood mononuclear cells (PBM) of seven CF patients with allergy, of six patients without allergy and of nine healthy subjects as well as in BAL cells of four patients and of all controls. PBM from six patients were incubated with recombinant human IL-13 or human antiIL-13 antibody without and with LPS stimulation and TNFalpha levels were measured by ELISA.
RESULTS: IL-13 mRNA expression was increased in allergic and non-allergic patients compared to controls. No significant difference in IL-4 expression could be found between patients and controls. Addition of IL-13 decreased TNFalpha in PBM culture supernatants.
CONCLUSION: Our data suggest that IL-13 rather than IL-4 might play an important role in both allergic and non-allergic CF patients. IL-13 might also compromise host defence by decreasing TNFalpha production. Copyright 2003 European Cystic Fibrosis Society

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15463872     DOI: 10.1016/S1569-1993(03)00091-2

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  8 in total

1.  Mucus in chronic airway diseases: sorting out the sticky details.

Authors:  Lauren Cohn
Journal:  J Clin Invest       Date:  2006-02       Impact factor: 14.808

2.  Airway epithelial homeostasis and planar cell polarity signaling depend on multiciliated cell differentiation.

Authors:  Eszter K Vladar; Jayakar V Nayak; Carlos E Milla; Jeffrey D Axelrod
Journal:  JCI Insight       Date:  2016-08-18

3.  Modulation of exaggerated-IgE allergic responses by gene transfer-mediated antagonism of IL-13 and IL-17e.

Authors:  Christian Mueller; Allison Keeler; Sofia Braag; Timothy Menz; Qiushi Tang; Terence R Flotte
Journal:  Mol Ther       Date:  2009-11-24       Impact factor: 11.454

Review 4.  Sputum biomarkers of inflammation in cystic fibrosis lung disease.

Authors:  Scott D Sagel; James F Chmiel; Michael W Konstan
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

Review 5.  Gene therapy for cystic fibrosis.

Authors:  Christian Mueller; Terence R Flotte
Journal:  Clin Rev Allergy Immunol       Date:  2008-12       Impact factor: 8.667

6.  Biofilm-Induced Type 2 Innate Immunity in a Cystic Fibrosis Model of Pseudomonas aeruginosa.

Authors:  Kenny Bielen; Bart 's Jongers; Jan Boddaert; Tom K Raju; Christine Lammens; Surbhi Malhotra-Kumar; Philippe G Jorens; Herman Goossens; Samir Kumar-Singh
Journal:  Front Cell Infect Microbiol       Date:  2017-06-21       Impact factor: 5.293

7.  Evaluation of genome-wide expression profiles of blood and sputum neutrophils in cystic fibrosis patients before and after antibiotic therapy.

Authors:  Massimo Conese; Stefano Castellani; Silvia Lepore; Orazio Palumbo; Antonio Manca; Teresa Santostasi; Angela Maria Polizzi; Massimiliano Copetti; Sante Di Gioia; Valeria Casavola; Lorenzo Guerra; Anna Diana; Pasqualina Montemurro; Maria Addolorata Mariggiò; Crescenzio Gallo; Angela Bruna Maffione; Massimo Carella
Journal:  PLoS One       Date:  2014-08-01       Impact factor: 3.240

8.  Paracellular bicarbonate flux across human cystic fibrosis airway epithelia tempers changes in airway surface liquid pH.

Authors:  Ian M Thornell; Tayyab Rehman; Alejandro A Pezzulo; Michael J Welsh
Journal:  J Physiol       Date:  2020-07-24       Impact factor: 6.228

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.